Al Janaby, T. (2025) “Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma”, World Journal of Oncology, 16(3), pp. 254–268. doi:10.14740/wjon2552.